The effect of perioperative intravenously administered iron isomaltoside 1000 (Monofer®) on transfusion requirements for patients undergoing complex valvular heart surgery: Study protocol for a randomized controlled trial

Trials

Volumn 19, Issue 1, 2018, Pages

  Lee, Seung Hyun ^a   Shim, Jae Kwang ^b   Soh, Sarah ^b   Song, Jong Wook ^b   Chang, Byung Chul ^a   Lee, Sak ^a   Kwak, Young Lan ^b  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Anemia; Complex valvular heart surgery; Iron isomaltoside 1000; Transfusion

Indexed keywords

BIOLOGICAL MARKER; HEPCIDIN; IRON ISOMALTOSE; PLACEBO; SODIUM CHLORIDE; DISACCHARIDE; FERRIC ION; IRON ISOMALTOSIDE 1000;

ACUTE KIDNEY FAILURE; ADULT; ALL CAUSE MORTALITY; ARTICLE; ASSISTED VENTILATION; BLOOD TRANSFUSION; CLINICAL OUTCOME; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DELAYED VENTILATOR THERAPY; DOUBLE BLIND PROCEDURE; FEMALE; FERRITIN BLOOD LEVEL; HEART VALVE SURGERY; HEMOGLOBIN BLOOD LEVEL; HUMAN; IRON BINDING CAPACITY; IRON BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PERIOPERATIVE PERIOD; POSTOPERATIVE CARE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REOPERATION; RETICULOCYTE COUNT; TRANSFERRIN BLOOD LEVEL; YOUNG ADULT; HEART VALVE; INTRAVENOUS DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); SURGERY;

ADMINISTRATION, INTRAVENOUS; ADULT; BLOOD TRANSFUSION; DISACCHARIDES; DOUBLE-BLIND METHOD; FERRIC COMPOUNDS; HEART VALVES; HUMANS; PERIOPERATIVE CARE; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 85049521188     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/s13063-018-2545-3     Document Type: Article

References (22)

1. Butler J, Rocker GM, Westaby S. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg. 1993;55(2):552-9.
2. Huyzen RJ, van Oeveren W, Wei F, Stellingwerf P, Boonstra PW, Gu YJ. In vitro effect of hemodilution on activated clotting time and high-dose thrombin time during cardiopulmonary bypass. Ann Thorac Surg. 1996;62(2):533-7.
3. Leal-Noval SR, Rincon-Ferrari MD, Garcia-Curiel A, et al. Transfusion of blood components and postoperative infection in patients undergoing cardiac surgery. Chest. 2001;119(5):1461-8.
4. De Santo LS, Romano G, Galdieri N, et al. RIFLE criteria for acute kidney injury in valvular surgery. J Heart Valve Dis. 2010;19(1):139-47. discussion 148
5. Bucerius J, Gummert JF, Borger MA, et al. Stroke after cardiac surgery: a risk factor analysis of 16,184 consecutive adult patients. Ann Thorac Surg. 2003;75(2):472-8.
6. Koch CG, Li L, Van Wagoner DR, Duncan AI, Gillinov AM, Blackstone EH. Red cell transfusion is associated with an increased risk for postoperative atrial fibrillation. Ann Thorac Surg. 2006;82(5):1747-56.
7. Silverberg DS, Iaina A, Peer G, et al. Intravenous iron supplementation for the treatment of the anemia of moderate to severe chronic renal failure patients not receiving dialysis. Am J Kidney Dis. 1996;27(2):234-8.
8. Rohling RG, Zimmermann AP, Breymann C. Intravenous versus oral iron supplementation for preoperative stimulation of hemoglobin synthesis using recombinant human erythropoietin. J Hematother Stem Cell Res. 2000;9(4):497-500.
9. Schaefer RM, Schaefer L. Iron monitoring and supplementation: how do we achieve the best results? Nephrol Dial Transplant. 1998;13(Suppl 2):9-12.
10. Macdougall IC. Strategies for iron supplementation: oral versus intravenous. Kidney Int Suppl. 1999;69:S61-6.
11. Berniere J, Dehullu JP, Gall O, Murat I. Intravenous iron in the treatment of postoperative anemia in surgery of the spine in infants and adolescents. Rev Chir Orthop Reparatrice Appar Mot. 1998;84(4):319-22.
12. Ranucci M, Baryshnikova E, Castelvecchio S, Pelissero G. Major bleeding, transfusions, and anemia: the deadly triad of cardiac surgery. Ann Thorac Surg. 2013;96(2):478-85.
13. Bregman DB, Morris D, Koch TA, He A, Goodnough LT. Hepcidin levels predict nonresponsiveness to oral iron therapy in patients with iron deficiency anemia. Am J Hematol. 2013;88(2):97-101.
14. Molitoris BA, Levin A, Warnock DG, et al. Improving outcomes from acute kidney injury. J Am Soc Nephrol. 2007;18(7):1992-4.
15. Froessler B, Palm P, Weber I, Hodyl NA, Singh R, Murphy EM. The important role for intravenous iron in perioperative patient blood management in major abdominal surgery: a randomized controlled trial. Ann Surg. 2016;264(1):41-6.
16. Munoz M, Gomez-Ramirez S, Cuenca J, et al. Very-short-term perioperative intravenous iron administration and postoperative outcome in major orthopedic surgery: a pooled analysis of observational data from 2547 patients. Transfusion. 2014;54(2):289-99.
17. Scott BH, Seifert FC, Grimson R. Blood transfusion is associated with increased resource utilisation, morbidity and mortality in cardiac surgery. Ann Card Anaesth. 2008;11(1):15-9.
18. Kiyama H, Ohshima N, Imazeki T, Yamada T. Autologous blood donation with recombinant human erythropoietin in anemic patients. Ann Thorac Surg. 1999;68(5):1652-6.
19. Gombotz H. Subcutaneous epoetin alfa as an adjunct to autologous blood donation before elective coronary artery bypass graft surgery. Semin Hematol. 1996;33(2 Suppl 2):69-70. discussion 71-62
20. Yoo YC, Shim JK, Kim JC, Jo YY, Lee JH, Kwak YL. Effect of single recombinant human erythropoietin injection on transfusion requirements in preoperatively anemic patients undergoing valvular heart surgery. Anesthesiology. 2011;115(5):929-37.
21. Johansson PI, Rasmussen AS, Thomsen LL. Intravenous iron isomaltoside 1000 (Monofer(R)) reduces postoperative anaemia in preoperatively non-anaemic patients undergoing elective or subacute coronary artery bypass graft, valve replacement or a combination thereof: a randomized double-blind placebo-controlled clinical trial (the PROTECT trial). Vox Sang. 2015;109(3):257-66.
22. Garrido-Martin P, Nassar-Mansur MI, de la Llana-Ducros R, et al. The effect of intravenous and oral iron administration on perioperative anaemia and transfusion requirements in patients undergoing elective cardiac surgery: a randomized clinical trial. Interact Cardiovasc Thorac Surg. 2012;15(6):1013-8.